Literature DB >> 16963664

Abnormalities on chest radiograph reported in subjects in a cancer screening trial.

Paul F Pinsky1, Matthew Freedman, Paul Kvale, Martin Oken, Neal Caporaso, John Gohagan.   

Abstract

BACKGROUND: Chest radiographs (CXRs) are commonly performed for diagnostic and other purposes. There is little literature either on the prevalence in the general population of various abnormalities seen on CXRs or on the risks associated with these abnormalities.
METHODS: We followed up > 70,000 men and women who were enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Subjects received four annual posteroanterior CXRs for the early detection of lung cancer. Radiologists noted the presence of non-cancer-related abnormalities as well as nodules/masses that were suspicious for lung cancer. Subjects were followed up for mortality and cancer incidence.
RESULTS: Abnormalities that were not suspicious for lung cancer were observed on 35% of examinations, compared to 8% of examinations with findings that were suspicious for cancer. The most commonly reported noncancer abnormalities were granuloma (10.7% of examinations), scarring/pulmonary fibrosis (8.2% of examinations), bone/soft tissue lesions (5.5% of examinations), cardiac abnormalities (4.4% of examinations), pleural fibrosis (3.6% of examinations), and COPD/emphysema (2.5% of examinations). Most noncancer abnormalities were more prevalent in men, older subjects, and smokers. Controlling for age, smoking, and other factors, scarring/pulmonary fibrosis was significantly associated with an increased risk of lung cancer with a hazard ratio (HR) of 2.0, while cardiac abnormalities (HR, 2.1), scarring/pulmonary fibrosis (HR, 1.4), COPD (HR, 1.7), and pleural fluid (HR, 2.3) were significantly associated with increased overall (ie, non-lung cancer) mortality.
CONCLUSION: Abnormalities that are not suspicious for lung cancer are common in a population undergoing screening. Some of these abnormalities are associated with an increased risk for lung cancer incidence and/or overall mortality.

Entities:  

Mesh:

Year:  2006        PMID: 16963664     DOI: 10.1378/chest.130.3.688

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

1.  Prevalence of non-cancer-related abnormalities on low-dose spiral computer tomography versus chest radiograph in a screening population.

Authors:  Paul Pinsky; Matthew Freedman; Martin Oken; Paul Kvale; Neal Caporaso; John Gohagan
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

2.  Circulating markers of interstitial lung disease and subsequent risk of lung cancer.

Authors:  Meredith S Shiels; Anil K Chaturvedi; Hormuzd A Katki; Bernadette R Gochuico; Neil E Caporaso; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-08-09       Impact factor: 4.254

3.  Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  Ying-Ying Yu; Paul F Pinsky; Neil E Caporaso; Nilanjan Chatterjee; Mona Baumgarten; Patricia Langenberg; Jon P Furuno; Qing Lan; Eric A Engels
Journal:  Arch Intern Med       Date:  2008-11-24

Review 4.  Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.

Authors:  Anja Van't Hoog; Kerri Viney; Olivia Biermann; Bada Yang; Mariska Mg Leeflang; Miranda W Langendam
Journal:  Cochrane Database Syst Rev       Date:  2022-03-23

5.  Artificial Intelligence-Based Identification of Normal Chest Radiographs: A Simulation Study in a Multicenter Health Screening Cohort.

Authors:  Hyunsuk Yoo; Eun Young Kim; Hyungjin Kim; Ye Ra Choi; Moon Young Kim; Sung Ho Hwang; Young Joong Kim; Young Jun Cho; Kwang Nam Jin
Journal:  Korean J Radiol       Date:  2022-10       Impact factor: 7.109

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.